The coronavirus pandemic defined 2020, upending our lives and bringing unprecedented shocks to markets and investors. Next year, however, is looking a whole lot brighter.
Make no mistake: As we cross into the new year, the virus is still raging, with new infections near peaks in the U.S. and much of Europe, where millions of people are living under strict lockdowns.
The much-heralded rollout of the Covid-19 vaccines isn’t going as smoothly as hoped. The U.S. is expected to miss President Donald Trump’s target to inoculate 20 million Americans by year-end. In the European Union, there is squabbling among member states over who gets how many vaccines and when.